Parents
for Vaccine Education UK
ALL
INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS NOT
TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE. THE DECISION WHETHER
OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND IS YOURS, AND YOURS
ALONE.
UK vaccination information Proof Scandals Home AUTISM
research Polio Challenging
Thoughts
Recommended books Helpful Links and Phone numbers The
Pharma and their conflict of interests
Thimerasol:
Overlooked danger, simple greed or just a poorly
disguised way of population reduction?
With the uncovering of the dangers of thimerosal, one can't help but wonder
whether the continued use of thimerosal in drugs, despite the knowledge of its
dangers, which was being kept secret for some 70 years by its developers, is
based on sheer greed, or if indeed it is just one part of an overall picture
that many wish to turn a blind eye because it is so overwhelming, so
unbelievable, that life is easier without knowing the whole story. In the years
of researching vaccines and their dangers and safety I met many children or
parents of children who were perfectly fine before a vaccination and then
started to regress in their development shortly after a vaccination. But I also
met many who appeared to have no effects whatsoever. Fair enough, the actual
long time side-effects are still not known, since no relevant independent
studies exist that might draw a conclusion between allergies and other diseases
that have been rapidly rising for the past 50 or so years. But then, why do
such studies not exist? All the studies that have 'proven' that there is no
link or lacked the proof that there is a link between thimerosal and autism,
allergies and several other diseases, have exclusively been financed with funds
from the pharmaceutical giants.
Something I have noticed is that those children who suffer severe side
effects (including death) appeared to follow a difficult pregnancy or
were premature, or not breastfed. This conclusion is entirely based on my
observations from talking with parents. It appears that more children die of
SIDS or shaken baby syndrome following the DTP vaccine. The DTP contains both
thimerosal and aluminium phosphate. In 1972 the British Medical Journal
reported a case of skin burns resulting from the chemical interaction of
thimerosal and aluminium. "Mercury is known to act as a catalyst and to
cause aluminium to oxidize rapidly, with the production of heat." "
The manufacturers who supply us with thimerosal have been informed." The
ingredients for the DTP vaccines today are aluminum phosphate, formaldehyde,
ammonium sulfate, washed sheep red blood cells, glycerol, sodium chloride, and
thimerosal, grown on porcine pancreatic hydrolysate of casein. Why did the
manufacturers not study the findings that were published in the British Medical
Journal?
Thimerosal contains four main ingredients: ethyl mercuric chloridge,
thiosalicylic acid, sodium hydroxide and ethanol of which approximately 50% is
mercury in weight. Mercury is known to cause neurotoxic reactions in
humans. Although the amount of mercury in thimerosal is very low, infants and
young children have much lower tolerance of mercury levels for neurological
disorders to develop than adults. After vaccination, hypersensitivity has been
noted, but no other harmful effects have been reported. However, overdoses of
thimerosal containing products have resulted in toxicity.
Although the the Public Health Service (including the FDA, National
Institutes of Health (NIH), Center for Disease
Control and Prevention (CDC) and Health
Resources and Services Administration (HRSA)
and the American Academy of Pediatrics issued two Joint Statements, urging
vaccine manufacturers to reduce or eliminate thimerosal in vaccines as soon as
possible (CDC
1999) and (CDC
2000), to this day, many vaccines still contain thimerosal (see tables
below).
The following vaccines still contain thimerasol:
*Vaccines for Children are in Bold
VACCINE TYPE |
BRAND NAME
(MANUFACTURER) |
|
|
CONTAIN THIMEROSAL |
DO NOT CONTAIN
THIMEROSAL |
DTaP |
Certiva (NAV) |
Infanrix (SKB) |
DTwP (whole-cell pertussis) |
Tri-Immunol (W-L) |
|
DTwP-Hib combination |
All brands |
|
DT, Pediatric |
Generic (all manufacturers) |
|
Hepatitis B |
Engerix (SKB) Recombivax (Merck) |
|
Hib (Haemophilus influenza type b
conjugate) |
HibTiter (W-L) multiple-dose vial |
HibTiter (W-L) single dose vial Liquid PedvaxHIB (Merck) ActHIB (PMC) |
Influenza |
All brands |
|
IPV |
|
IPOL (PMC) |
Japanese Encephalitis |
JE-Vax (PMC) |
|
Meningococcal |
Menomune A,C,Y,W-135 (PMC) |
|
MMR |
|
Merck |
OPV |
|
Orimune (W-L) |
Pneumococcal |
Pnu-Immune (W-L) |
Pneumovax (Merck) |
Rabies |
Generic (Michigan, SKB) Rabavert (Chiron) |
Imovax--Human Diploid Cell (PMC) |
Rotavirus |
|
Rotashield (W-L) |
Td, Adult |
Generic (all manufacturers) |
|
Varicella |
|
Merck |
Hepatitis B Immune Globulin (HBIG) |
All manufacturers except Bayer |
BayHepB (Bayer) |
Immune Globulin (IG) |
All manufacturers except Bayer |
BayGam (Bayer) |
Tetanus Immune Globulin (TIG) |
Generic (Massachusetts) |
BayTet (Bayer) |
Varicella Zoster Immune Globulin (VZIG) |
Generic |
|
Diphtheria toxoid (single antigen) |
Generic (all manufacturers) |
|
Pertussis vaccine (whole cell, single-antigen) |
Generic (all manufacturers) |
|
Tetanus toxoid (single antigen) |
Generic (all manufacturers) |
|
U.S. Public Health Service
American Academy of Pediatrics
July 10, 1999
Source:
http://www.injury-lawyer-network.com/autvaccines.htm
From the FDA website:
Thimerosal Content in Some Currently
Manufactured U.S. Licensed Vaccines |
||||
Vaccine |
Trade Name |
Manufacturer |
Thimerosal
Concentration1 |
Mercury |
Anthrax |
Anthrax vaccine |
BioPort Corporation |
0 |
0 |
DTaP |
Tripedia2 |
Aventis Pasteur |
<0.0002% |
<0.5µg/dose |
Infanrix |
GlaxoSmithKline |
0 |
0 |
|
DT |
All Products |
|
0.01% |
25µg/dose |
Td |
All Products |
|
0.01% |
25µg/dose |
TT |
All Products |
|
0.01% |
25µg/dose |
Hib |
ActHIB/OmniHIB3 |
Aventis Pasteur |
0 |
0 |
HibTITER (Single dose) |
Wyeth-Lederle |
0 |
0 |
|
PedvaxHIB liquid |
Merck |
0 |
0 |
|
Hib/HepB |
COMVAX4 |
Merck |
0 |
0 |
Hepatitis B5 |
Engerix-B |
GlaxoSmithKline |
<0.0002% |
<0.5µg/dose |
Recombivax HB |
Merck |
0 |
0 |
|
Hepatitis A |
Havrix |
GlaxoSmithKline |
0 |
0 |
Vaqta |
Merck |
0 |
0 |
|
IPV |
IPOL |
Aventis Pasteur |
0 |
0 |
Poliovax |
Aventis Pasteur |
0 |
0 |
|
Influenza6 |
All |
Aventis Pasteur, Evans,
Wyeth-Lederle |
0.01% |
25 µg/0.5 mL dose |
Japanese Encephalitis7 |
JE-VAX |
BIKEN |
0.007% |
35 µg/1.0mL dose |
Lyme |
LYMErix |
GlaxoSmithKline |
0 |
0 |
MMR |
MMR-II |
Merck |
0 |
0 |
Meningococcal |
Menomune A, C, AC and
A/C/Y/W-135 |
Aventis Pasteur |
0.01% |
25 µg/dose |
Pneumococcal |
Prevnar (Pneumo Conjugate) |
Lederle Laboratories |
0 |
0 |
Pneumovax 23 |
Merck |
0 |
0 |
|
Pnu-Imune 23 |
Wyeth-Lederle |
0.01% |
25 µg/dose |
|
Rabies |
IMOVAX |
Aventis Pasteur |
0 |
0 |
Rabavert |
Chiron |
0 |
0 |
|
Typhoid Fever |
Typhim Vi |
Aventis Pasteur |
0 |
0 |
Typhoid Ty21a |
Swiss Serum and Vaccine
Institute |
0 |
0 |
|
Varicella |
Varivax |
Merck |
0 |
0 |
Yellow Fever |
Y-F-Vax |
Aventis Pasteur |
0 |
0 |
Table Footnotes
|